Results 141 to 150 of about 53,847 (189)

Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.

open access: yesElife, 2022
Fernández Álvaro E   +23 more
europepmc   +1 more source

Safety and Tolerability of ShigActive™, a <i>Shigella</i> spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial. [PDF]

open access: yesAntibiotics (Basel)
Chen WH   +14 more
europepmc   +1 more source

Mutational convergence acts as a major player in adaptive parallel evolution of Shigella spp. [PDF]

open access: yesSci Rep, 2019
Thomas AK   +6 more
europepmc   +1 more source

Genome-wide association studies of Shigella spp. and Enteroinvasive Escherichia coli isolates demonstrate an absence of genetic markers for prediction of disease severity. [PDF]

open access: yesBMC Genomics, 2020
Hendriks ACA   +7 more
europepmc   +1 more source

Temporal GWAS identifies a widely distributed putative adhesin contributing to pathogen success in Shigella spp

open access: yes, 2022
Bennett RJ   +5 more
europepmc   +1 more source

Complete Genome Sequence of a Novel Myoviridae Phage, SfΦ01, Infecting Shigella spp. [PDF]

open access: yesMicrobiol Resour Announc, 2019
Kitajima M, Ishii S, Takagi T, Okabe S.
europepmc   +1 more source

Azithromycin Resistance in Shigella spp. in Southeast Asia. [PDF]

open access: yesAntimicrob Agents Chemother, 2018
Darton TC   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy